- Home
- Publications
- Publication Search
- Publication Details
Title
Liquid Biopsies in Hepatocellular Carcinoma: Are We Winning?
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 9, Issue 5, Pages 1541
Publisher
MDPI AG
Online
2020-05-20
DOI
10.3390/jcm9051541
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circulating miR-26a, miR-106b, miR-107 and miR-133b stratify hepatocellular carcinoma patients according to their response to transarterial chemoembolization
- (2019) Hamdy E.A. Ali et al. CLINICAL BIOCHEMISTRY
- Extracellular Vesicles in Liver Diseases: Diagnostic, Prognostic, and Therapeutic Application
- (2019) Sabine Urban et al. SEMINARS IN LIVER DISEASE
- Identification of plasma miR-148a as a noninvasive biomarker for hepatocellular carcinoma
- (2019) Juqiang Han et al. Clinics and Research in Hepatology and Gastroenterology
- Liquid Biopsies in Cancer Diagnosis, Monitoring, and Prognosis
- (2019) Gabriele De Rubis et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Detection of early-stage hepatocellular carcinoma in asymptomatic HBsAg-seropositive individuals by liquid biopsy
- (2019) Chunfeng Qu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Serum MicroRNAs as Biomarkers in Hepatitis C: Preliminary Evidence of a MicroRNA Panel for the Diagnosis of Hepatocellular Carcinoma
- (2019) Anna Weis et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Circulating microRNA‐1246 as a possible biomarker for early tumor recurrence of hepatocellular carcinoma
- (2019) Makoto Chuma et al. HEPATOLOGY RESEARCH
- Biomarkers Associated With Response to Regorafenib in Patients With Hepatocellular Carcinoma
- (2019) Michael Teufel et al. GASTROENTEROLOGY
- Next-Generation Cancer Immunotherapy Targeting Glypican-3
- (2019) Yasuhiro Shimizu et al. Frontiers in Oncology
- Molecular profiling of hepatocellular carcinoma using circulating cell-free DNA
- (2019) Ahmed O Kaseb et al. CLINICAL CANCER RESEARCH
- Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma
- (2019) Jessica Howell et al. EUROPEAN JOURNAL OF CANCER
- Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma
- (2019) Jiabin Cai et al. GUT
- Circulating pro- and anti-angiogenic factors in multi-stage liver disease and hepatocellular carcinoma progression
- (2019) Yu Young Joo et al. Scientific Reports
- Detection of a novel panel of somatic mutations in plasma cell-free DNA and its diagnostic value in hepatocellular carcinoma
- (2019) Yu Xiong et al. Cancer Management and Research
- Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial
- (2019) Marianna Alunni-Fabbroni et al. Journal of Translational Medicine
- Biology and significance of alpha‐fetoprotein in hepatocellular carcinoma
- (2019) Peter R. Galle et al. LIVER INTERNATIONAL
- Genetic profiling using plasma-derived cell-free DNA in therapy-naïve hepatocellular carcinoma patients: a pilot study
- (2018) C K Y Ng et al. ANNALS OF ONCOLOGY
- Diagnosis, Staging and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
- (2018) Jorge A. Marrero et al. HEPATOLOGY
- cHCC-CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation
- (2018) Elizabeth Brunt et al. HEPATOLOGY
- Diagnostic value of circulating cell-free DNA levels for hepatocellular carcinoma
- (2018) Linlin Yan et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- The Role of Circulating Free DNA and MicroRNA in Non-Invasive Diagnosis of HBV- and HCV-Related Hepatocellular Carcinoma
- (2018) et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Plasma MicroRNA-21, 26a, and 29a-3p as Predictive Markers for Treatment Response Following Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma
- (2018) Soon Sun Kim et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- A Novel Multimarker Assay for the Phenotypic Profiling of Circulating Tumor Cells in Hepatocellular Carcinoma
- (2018) Colin M. Court et al. LIVER TRANSPLANTATION
- A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma
- (2018) Ismail Labgaa et al. ONCOGENE
- Detection and localization of surgically resectable cancers with a multi-analyte blood test
- (2018) Joshua D. Cohen et al. SCIENCE
- LIQUID BIOPSIES FOR HEPATOCELLULAR CARCINOMA
- (2018) Ying-Hsiu Su et al. Translational Research
- Novel serum microRNAs panel on the diagnostic and prognostic implications of hepatocellular carcinoma
- (2018) Yang An et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma
- (2018) Farzaneh Moshiri et al. Oncotarget
- Serum exosomal microRNAs combined with alpha-fetoprotein as diagnostic markers of hepatocellular carcinoma
- (2018) Yurong Wang et al. Cancer Medicine
- Extracellular Vesicle-Associated mir-21 and mir-144 Are Markedly Elevated in Serum of Patients With Hepatocellular Carcinoma
- (2018) Chunwen Pu et al. Frontiers in Physiology
- Plasma m SEPT9 : A Novel Circulating Cell-free DNA-Based Epigenetic Biomarker to Diagnose Hepatocellular Carcinoma
- (2018) Abderrahim Oussalah et al. EBioMedicine
- Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
- (2018) Jie Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Circulating tumor DNA – Current state of play and future perspectives
- (2018) Gabriele De Rubis et al. PHARMACOLOGICAL RESEARCH
- High-density single cell mRNA sequencing to characterize circulating tumor cells in hepatocellular carcinoma
- (2018) Delia D’Avola et al. Scientific Reports
- Meta-analysis of circulating microRNAs for the diagnosis of hepatocellular carcinoma
- (2018) Cheng Peng et al. DIGESTIVE AND LIVER DISEASE
- Serum metabolites as diagnostic biomarkers for cholangiocarcinoma, hepatocellular carcinoma and primary sclerosing cholangitis
- (2018) Jesus M Banales et al. HEPATOLOGY
- High Epithelial Cell Adhesion Molecule–Positive Circulating Tumor Cell Count Predicts Poor Survival of Patients with Unresectable Hepatocellular Carcinoma Treated with Transcatheter Arterial Chemoembolization
- (2018) Jian Shen et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Specificities of secretion and uptake of exosomes and other extracellular vesicles for cell-to-cell communication
- (2018) Mathilde Mathieu et al. NATURE CELL BIOLOGY
- Preferred end coordinates and somatic variants as signatures of circulating tumor DNA associated with hepatocellular carcinoma
- (2018) Peiyong Jiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Large Extracellular Vesicles: Have We Found the Holy Grail of Inflammation?
- (2018) Artur Słomka et al. Frontiers in Immunology
- Serum extracellular vesicles contain protein biomarkers for primary sclerosing cholangitis and cholangiocarcinoma
- (2017) Ander Arbelaiz et al. HEPATOLOGY
- HepPar1-Positive Circulating Microparticles Are Increased in Subjects with Hepatocellular Carcinoma and Predict Early Recurrence after Liver Resection
- (2017) Valeria Abbate et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cancer-associated circulating large extracellular vesicles in cholangiocarcinoma and hepatocellular carcinoma
- (2017) Henrike Julich-Haertel et al. JOURNAL OF HEPATOLOGY
- Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma
- (2017) Ao Huang et al. JOURNAL OF HEPATOLOGY
- Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment
- (2017) Fubo Zhou et al. MEDICINAL RESEARCH REVIEWS
- Serum microRNA panel for early diagnosis of the onset of hepatocellular carcinoma
- (2017) Ying Zhang et al. MEDICINE
- The diagnostic value of assays for circulating tumor cells in hepatocellular carcinoma
- (2017) Chi Sun et al. MEDICINE
- Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma
- (2017) Rui-hua Xu et al. NATURE MATERIALS
- Expansion of patient-derived circulating tumor cells from liquid biopsies using a CTC microfluidic culture device
- (2017) Bee Luan Khoo et al. Nature Protocols
- Targeted deep sequencing of plasma circulating cell-free DNA reveals Vimentin and Fibulin 1 as potential epigenetic biomarkers for hepatocellular carcinoma
- (2017) Reetta Holmila et al. PLoS One
- An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma
- (2017) Mark Kalinich et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma
- (2017) Bao-Min Shi et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids
- (2017) Wataru Okajima et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Low levels of circulating microRNA-26a/29a as poor prognostic markers in patients with hepatocellular carcinoma who underwent curative treatment
- (2017) Hyo Jung Cho et al. Clinics and Research in Hepatology and Gastroenterology
- Circulating tumor cells as liquid biomarker for high HCC recurrence risk after curative liver resection
- (2017) Johann von Felden et al. Oncotarget
- Circulating miR-21 serves as a serum biomarker for hepatocellular carcinoma and correlated with distant metastasis
- (2017) Xin Guo et al. Oncotarget
- Circulating miRNAs as novel diagnostic biomarkers in hepatocellular carcinoma detection: a meta-analysis based on 24 articles
- (2017) Yan Ding et al. Oncotarget
- The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level
- (2017) et al. JAMA Oncology
- Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection
- (2016) Yan Zhou et al. BMC CANCER
- AFP mRNA level in enriched circulating tumor cells from hepatocellular carcinoma patient blood samples is a pivotal predictive marker for metastasis
- (2016) Junhua Jin et al. CANCER LETTERS
- Acetylcarnitine Is a Candidate Diagnostic and Prognostic Biomarker of Hepatocellular Carcinoma
- (2016) Y. Lu et al. CANCER RESEARCH
- Personalized therapy for hepatocellular carcinoma: Where are we now?
- (2016) Stephen L. Chan et al. CANCER TREATMENT REVIEWS
- Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers
- (2016) Chang-Qing Yin et al. DISEASE MARKERS
- The potential role of miRNAs 21 and 199-a in early diagnosis of hepatocellular carcinoma
- (2016) Khalda Said Amr et al. GENE
- An improved strategy to detect the epithelial-mesenchymal transition process in circulating tumor cells in hepatocellular carcinoma patients
- (2016) Yong-kang Liu et al. Hepatology International
- Evaluation of Circulatory RNA-Based Biomarker Panel in Hepatocellular Carcinoma
- (2016) Ahmed Hassan Fawzi El-Tawdi et al. Molecular Diagnosis & Therapy
- Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection
- (2016) Abdel-Rahman Nabawy Zekri et al. TUMOR BIOLOGY
- Serum miR-21, miR-26a and miR-101 as potential biomarkers of hepatocellular carcinoma
- (2016) Chunbo Zhuang et al. Clinics and Research in Hepatology and Gastroenterology
- Circulating microRNA profiles in plasma: identification of miR-224 as a novel diagnostic biomarker in hepatocellular carcinoma independent of hepatic function
- (2016) Wataru Okajima et al. Oncotarget
- Cell-free methylation markers with diagnostic and prognostic potential in hepatocellular carcinoma
- (2016) Chang-Yi Lu et al. Oncotarget
- Perioperative plasma glypican-3 level may enable prediction of the risk of recurrence after surgery in patients with stage I hepatocellular carcinoma
- (2016) Kazuya Ofuji et al. Oncotarget
- Noninvasive detection of tumor-associated mutations from circulating cell-free DNA in hepatocellular carcinoma patients by targeted deep sequencing
- (2016) Wenjun Liao et al. Oncotarget
- Aptamer-Mediated Transparent-Biocompatible Nanostructured Surfaces for Hepatocellular Circulating Tumor Cells Enrichment
- (2016) Shuyi Wang et al. Theranostics
- Plasma Circulating Cell-free DNA Integrity as a Promising Biomarker for Diagnosis and Surveillance in Patients with Hepatocellular Carcinoma
- (2016) Ao Huang et al. Journal of Cancer
- Detecting Circulating Tumor DNA in Hepatocellular Carcinoma Patients Using Droplet Digital PCR Is Feasible and Reflects Intratumoral Heterogeneity
- (2016) Ao Huang et al. Journal of Cancer
- Metabolomic profiles of hepatocellular carcinoma in a European prospective cohort
- (2015) Anne Fages et al. BMC Medicine
- Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review
- (2015) T Kimhofer et al. BRITISH JOURNAL OF CANCER
- Biological and Therapeutic Impact of Intratumor Heterogeneity in Cancer Evolution
- (2015) Nicholas McGranahan et al. CANCER CELL
- Circulating Tumor Cells for Predicting the Prognostic of Patients with Hepatocellular Carcinoma: A Meta Analysis
- (2015) Jun-Li Fan et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- High circulating microRNA-122 expression is a poor prognostic marker in patients with hepatitis B virus-related hepatocellular carcinoma who undergo radiofrequency ablation
- (2015) Hyo Jung Cho et al. CLINICAL BIOCHEMISTRY
- Translational Implications of Tumor Heterogeneity
- (2015) M. Jamal-Hanjani et al. CLINICAL CANCER RESEARCH
- Update on Biomarkers of Hepatocellular Carcinoma
- (2015) Roongruedee Chaiteerakij et al. Clinical Gastroenterology and Hepatology
- Combination of exosomes and circulating microRNAs may serve as a promising tumor marker complementary to alpha-fetoprotein for early-stage hepatocellular carcinoma diagnosis in rats
- (2015) Wei-hui Liu et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients
- (2015) Peiyong Jiang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fifty years of discovery of alpha-fetoprotein as the first tumor marker
- (2015) Dina Nikulina et al. Srpski Arhiv za Celokupno Lekarstvo
- Comprehensive analysis of transcriptome and metabolome analysis in Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma
- (2015) Yoshiki Murakami et al. Scientific Reports
- Su2042 Serum VEGF as a Tumor Marker for Patients With HCV-Related Liver Cirrhosis and Hepatocellular Carcinoma
- (2015) Takanori Mukozu et al. GASTROENTEROLOGY
- Discovery and Diagnostic Value of a Novel Oncofetal Protein
- (2014) Sean K. Wang et al. ADVANCES IN ANATOMIC PATHOLOGY
- Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
- (2014) Marina Colombo et al. Annual Review of Cell and Developmental Biology
- Hepatocellular carcinoma tumour markers: Current role and expectations
- (2014) Nicole Rich et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis
- (2014) Carlos J Pirola et al. GUT
- NMR and LC/MS-based global metabolomics to identify serum biomarkers differentiating hepatocellular carcinoma from liver cirrhosis
- (2014) Yue Liu et al. INTERNATIONAL JOURNAL OF CANCER
- Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma
- (2014) Alessandro Cucchetti et al. JOURNAL OF HEPATOLOGY
- Metabolomics Study of Hepatocellular Carcinoma: Discovery and Validation of Serum Potential Biomarkers by Using Capillary Electrophoresis–Mass Spectrometry
- (2014) Jun Zeng et al. JOURNAL OF PROTEOME RESEARCH
- Development of Urinary Pseudotargeted LC-MS-Based Metabolomics Method and Its Application in Hepatocellular Carcinoma Biomarker Discovery
- (2014) Yaping Shao et al. JOURNAL OF PROTEOME RESEARCH
- Circulating Extracellular Vesicles with Specific Proteome and Liver MicroRNAs Are Potential Biomarkers for Liver Injury in Experimental Fatty Liver Disease
- (2014) Davide Povero et al. PLoS One
- Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility
- (2014) M. Yu et al. SCIENCE
- A novel biomarker Linc00974 interacting with KRT19 promotes proliferation and metastasis in hepatocellular carcinoma
- (2014) J Tang et al. Cell Death & Disease
- Metabolic Characterization of Hepatocellular Carcinoma Using Nontargeted Tissue Metabolomics
- (2013) Q. Huang et al. CANCER RESEARCH
- Sublethal heat treatment promotes epithelial-mesenchymal transition and enhances the malignant potential of hepatocellular carcinoma
- (2013) Shuhei Yoshida et al. HEPATOLOGY
- MicroRNA-21 regulates the migration and invasion of a stem-like population in hepatocellular carcinoma
- (2013) LIANG ZHOU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- MicroRNAs in liver disease
- (2013) Gyongyi Szabo et al. Nature Reviews Gastroenterology & Hepatology
- Circulating Tumor Cells
- (2013) V. Plaks et al. SCIENCE
- Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma
- (2012) J. M. Llovet et al. CLINICAL CANCER RESEARCH
- Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases
- (2012) Shashi Bala et al. HEPATOLOGY
- Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma
- (2012) Xijun Wang et al. HEPATOLOGY
- Serum Metabolic Profiling Study of Hepatocellular Carcinoma Infected with Hepatitis B or Hepatitis C Virus by Using Liquid Chromatography–Mass Spectrometry
- (2012) Lina Zhou et al. JOURNAL OF PROTEOME RESEARCH
- Metabolic phenotyping in clinical and surgical environments
- (2012) Jeremy K. Nicholson et al. NATURE
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Identification of serum biomarkers of hepatocarcinoma through liquid chromatography/mass spectrometry-based metabonomic method
- (2011) Feng Chen et al. ANALYTICAL AND BIOANALYTICAL CHEMISTRY
- Identification of osteopontin as a novel marker for early hepatocellular carcinoma
- (2011) Sufen Shang et al. HEPATOLOGY
- Glypican-3
- (2009) Dina H. Kandil et al. ADVANCES IN ANATOMIC PATHOLOGY
- Metabolomic profiling of human urine in hepatocellular carcinoma patients using gas chromatography/mass spectrometry
- (2009) Hao Wu et al. ANALYTICA CHIMICA ACTA
- MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma
- (2009) Yusuke Yamamoto et al. BIOMARKERS
- α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma
- (2009) Jorge A. Marrero et al. GASTROENTEROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started